Biotech Stocks Pause at Resistance: IBB…Update-2…Caution
Update-2... 9/29 Caution on Biotech-Major Sell-Off with IBB off 3.12% The market had a bad day today hit by Wells Fargo (WFC) Congressional hearings and paranoia about Deutsche Bank AG (DB). Unrelated to this news was a major sell-off in biotech stocks with pricing concerns back in the news....
Biotech ETFs Lead Q3 Rally: XBI Breaks Out
Biotech ETFs Are Having A Strong Quarter and Offer Good Investment Options On July 20 we did a review of active funds vs biotech ETFs in the biotechnology/life science sector just after the BREXIT lows. At that time biotech ETFs and broadly diversified funds beat the "pure play" biotechnology...
Stealth Biotech Rally With Momentum Rising…Update-1
Update-1...FED Goes on Hold with Rate Increase Likely by Year End Three on FOMC dissented wanting a rate hike this round. Market immediately rallied with NASDAQ up 1.03% at close; S&P and Dow also rally. Biotechs like low i rates:IBB up 0.62% to $297, XBI up 1.14% to $68.28 highest level...
Biopharma Stocks Show Resilience in Yo-Yo Week…Update-1
Biopharma Stocks Breeze through 'Quadruple Witching Day"...9/16 Healthcare stocks (XLV) were one of the leading sectors on a down day up a tiny bit to $72. The IBB held, up 0.57% to the $291 mark and up 4.75% for the week. The more volatile XBI was a tad weaker down 0.3% on the day. Large caps...
FED Fear Factor Fades then Biotechs Rally: AMGN,IBB…Update-1 Bearish Reversal
Update-1... 9/13... Hard to Call Next Move: Macro and i Rates Rule The market was rattled at the opening with the IEA news on cuts in the demand forecast for crude which dropped 2.33%. Subsequently FED hike fears returned causing more volatility with stocks and significantly a major move up in...